tiprankstipranks
Dawnrays Pharmaceutical Holdings Ltd. (HK:2348)
:2348
Hong Kong Market
2348
Dawnrays Pharmaceutical Holdings Ltd.
RESEARCH TOOLSreports

Dawnrays Pharmaceutical Holdings Ltd. (2348) Ratios

5 Followers

Dawnrays Pharmaceutical Holdings Ltd. Ratios

HK:2348's free cash flow for Q2 2025 was ¥0.46. For the 2025 fiscal year, HK:2348's free cash flow was decreased by ¥ and operating cash flow was ¥0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 4.64 3.97 2.57 1.87 2.17
Quick Ratio
 4.21 3.42 2.26 1.61 1.88
Cash Ratio
 2.36 2.09 1.35 0.87 0.83
Solvency Ratio
 0.50 0.94 0.54 0.42 0.44
Operating Cash Flow Ratio
 0.51 0.40 0.51 0.47 0.56
Short-Term Operating Cash Flow Coverage
 3.23 7.37 2.82 67.50 18.71
Net Current Asset Value
¥ 1.67B¥ 1.52B¥ 956.77M¥ 721.22M¥ 569.34M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 <0.01 0.03 <0.01 <0.01
Debt-to-Equity Ratio
 0.02 0.01 0.04 <0.01 <0.01
Debt-to-Capital Ratio
 0.02 0.01 0.04 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.18 1.21 1.27 1.39 1.40
Debt Service Coverage Ratio
 3.70 6.16 3.37 62.11 16.10
Interest Coverage Ratio
 1.27K 101.97 280.50 1.14K 594.01
Debt to Market Cap
 0.05 0.02 0.08 <0.01 0.01
Interest Debt Per Share
 0.05 0.03 0.08 <0.01 0.02
Net Debt to EBITDA
 -3.34 -4.01 -1.57 -1.59 -1.28
Profitability Margins
Gross Profit Margin
47.61%54.48%55.73%60.01%57.96%
EBIT Margin
18.53%19.06%36.06%34.34%32.68%
EBITDA Margin
26.69%26.45%43.34%39.54%37.24%
Operating Profit Margin
18.56%34.70%24.10%33.06%32.68%
Pretax Profit Margin
20.28%60.07%35.97%34.31%37.71%
Net Profit Margin
17.38%53.28%28.32%28.02%30.74%
Continuous Operations Profit Margin
17.14%53.08%28.03%27.85%30.40%
Net Income Per EBT
85.67%88.69%78.73%81.67%81.53%
EBT Per EBIT
109.25%173.13%149.25%103.79%115.38%
Return on Assets (ROA)
5.29%14.09%9.00%9.75%10.73%
Return on Equity (ROE)
6.34%16.99%11.42%13.55%15.04%
Return on Capital Employed (ROCE)
6.44%10.65%9.39%15.41%14.41%
Return on Invested Capital (ROIC)
5.33%9.33%7.03%13.73%12.76%
Return on Tangible Assets
6.07%16.29%10.12%10.78%11.94%
Earnings Yield
14.09%32.74%22.59%20.35%17.59%
Efficiency Ratios
Receivables Turnover
 4.60 2.08 3.58 3.17 3.36
Payables Turnover
 3.68 2.18 3.14 2.28 3.42
Inventory Turnover
 2.97 1.57 2.41 2.11 2.41
Fixed Asset Turnover
 1.04 0.86 0.94 0.98 1.02
Asset Turnover
 0.30 0.26 0.32 0.35 0.35
Working Capital Turnover Ratio
 0.70 0.79 1.24 1.57 1.24
Cash Conversion Cycle
 103.12 241.19 137.15 127.71 153.54
Days of Sales Outstanding
 79.33 175.64 102.10 115.08 108.63
Days of Inventory Outstanding
 123.01 233.09 151.20 172.67 151.63
Days of Payables Outstanding
 99.22 167.54 116.14 160.05 106.72
Operating Cycle
 202.33 408.73 253.29 287.76 260.27
Cash Flow Ratios
Operating Cash Flow Per Share
 0.17 0.15 0.23 0.29 0.26
Free Cash Flow Per Share
 0.13 0.03 0.08 0.15 0.05
CapEx Per Share
 0.04 0.12 0.14 0.14 0.21
Free Cash Flow to Operating Cash Flow
 0.78 0.20 0.37 0.53 0.20
Dividend Paid and CapEx Coverage Ratio
 1.34 0.77 1.03 1.43 0.86
Capital Expenditure Coverage Ratio
 4.57 1.25 1.60 2.12 1.26
Operating Cash Flow Coverage Ratio
 3.23 6.34 2.81 51.62 16.72
Operating Cash Flow to Sales Ratio
 0.21 0.21 0.29 0.34 0.34
Free Cash Flow Yield
13.00%2.58%8.76%13.06%3.93%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 7.19 3.05 4.43 4.92 5.69
Price-to-Sales (P/S) Ratio
 1.25 1.63 1.25 1.38 1.75
Price-to-Book (P/B) Ratio
 0.45 0.52 0.51 0.67 0.86
Price-to-Free Cash Flow (P/FCF) Ratio
 7.78 38.71 11.42 7.65 25.44
Price-to-Operating Cash Flow Ratio
 6.08 7.84 4.26 4.05 5.18
Price-to-Earnings Growth (PEG) Ratio
 0.43 0.04 -0.53 0.00 0.14
Price-to-Fair Value
 0.45 0.52 0.51 0.67 0.86
Enterprise Value Multiple
 1.34 2.15 1.32 1.89 3.42
Enterprise Value
 416.99M 601.73M 657.61M 956.61M 1.48B
EV to EBITDA
 1.28 2.15 1.32 1.89 3.42
EV to Sales
 0.34 0.57 0.57 0.75 1.27
EV to Free Cash Flow
 2.13 13.50 5.20 4.16 18.51
EV to Operating Cash Flow
 1.66 2.73 1.94 2.20 3.77
Tangible Book Value Per Share
 1.91 1.85 1.64 1.53 1.37
Shareholders’ Equity Per Share
 2.25 2.21 1.90 1.76 1.59
Tax and Other Ratios
Effective Tax Rate
 0.15 0.12 0.22 0.19 0.19
Revenue Per Share
 0.81 0.70 0.77 0.85 0.78
Net Income Per Share
 0.14 0.38 0.22 0.24 0.24
Tax Burden
 0.86 0.89 0.79 0.82 0.82
Interest Burden
 1.09 3.15 1.00 1.00 1.15
Research & Development to Revenue
 0.07 0.07 0.08 0.06 0.06
SG&A to Revenue
 0.20 0.24 0.10 0.10 0.10
Stock-Based Compensation to Revenue
 <0.01 >-0.01 >-0.01 >-0.01 <0.01
Income Quality
 1.42 0.35 0.82 1.21 1.10
Currency in CNY